EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
AngioDynamics, Inc. (ANGO) had EBIT Margin of -9.02% for the most recently reported fiscal quarter, ending 2026-08-31.
| Income Statement Financials | |
$80.92M |
|
$-7.10M |
|
$32.88M |
|
$48.04M |
|
$88.22M |
|
$-7.30M |
|
$0.01M |
|
$-7.30M |
|
$-7.30M |
|
$-7.10M |
|
$-7.10M |
|
$-7.10M |
|
$-7.10M |
|
$-7.30M |
|
$-1.80M |
|
42.02M |
|
42.02M |
|
$-0.17 |
|
$-0.17 |
|
| Balance Sheet Financials | |
$143.00M |
|
$27.73M |
|
$98.93M |
|
$241.93M |
|
$59.69M |
|
-- |
|
$18.28M |
|
$77.97M |
|
$163.96M |
|
$102.07M |
|
$163.96M |
|
42.42M |
|
| Cash Flow Statement Financials | |
$-15.33M |
|
$-3.15M |
|
$-1.38M |
|
$53.86M |
|
$33.97M |
|
$-19.89M |
|
$4.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
59.37% |
|
-9.02% |
|
|
EBIT Margin |
-9.02% |
-- |
|
-9.02% |
|
-8.77% |
|
$-15.71M |
|
-- |
|
-- |
|
-- |
|
0.33 |
|
0.60 |
|
1.80 |
|
49.95 |
|
-4.33% |
|
-6.95% |
|
-2.93% |
|
-4.33% |
|
$3.86 |
|
$-0.37 |
|
$-0.36 |
|